Editorial: Cytopathic pathways of enteroviral myocardial infection

European Heart Journal

Volumn 31, Issue 6, 2010, Pages 637-639

  Frustaci, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA INTERFERON; CARVEDILOL; CASPASE INHIBITOR; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; VASODILATOR AGENT;

APOPTOSIS; DRUG MEGADOSE; EDITORIAL; ENTEROVIRUS INFECTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; MYOCARDITIS; PRIORITY JOURNAL; HEART MITOCHONDRION; NOTE; VIROLOGY; VIRUS CELL TRANSFORMATION;

APOPTOSIS; CELL TRANSFORMATION, VIRAL; ENTEROVIRUS INFECTIONS; HUMANS; MITOCHONDRIA, HEART; MYOCARDITIS; MYOCYTES, CARDIAC;

EID: 77954161671     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp569     Document Type: Editorial

References (14)

1. Cooper LT Jr. Myocarditis. N Engl J Med. 2009. 360.1526-1538.
2. Noutsias M, Pauschinger M, Schultheiss HP, Kühl U. Cytotoxic perforin\+ and TIA-1\+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail 2003;5:469-479.
3. Rose NR. Viral damage or 'molecular mimicry'\placing the blame in myocarditis. Nat Med 2000;6:631-632.
4. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: evidence of cyto-skeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-326.
5. Ventéo L, Bourlet T, Renois F, Douche-Aourik F, Mosnier J-F, Lorain De la Grand Maison G, Pluot M, Pozzetto B, Andreoletti L. Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis. Eur Heart J 2010;31:728-736. First published on 19 November 2009. doi: 10.1093/eurheartj/ehp489.
6. Maisch B, Hufnagel G, Kölsch S, Funck R, Richter A, Rupp H, Herzum M, Pankuweit S. Treatment of inflammatory dilated cardiomyopathy and (peri)myo-carditis with immunosuppression and i.v. immunoglobulins. Herz 2004;29: 624-636.
7. Felix SB, Staudt A. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int J Cardiol 2006;112: 30-33.
8. Fechner H, Pinkert S, Wang X, Sipo I, Suckau L, Kurreck J, Dö rner A, Sollerbrant K, Zeichhardt H, Grunert HP, Vetter R, Schultheiss HP, Poller W. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther 2007;14:960-971.
9. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003;107: 2793-2798.
10. Bodur H, Savran Y, Koca U, Kilinç O, Albayrak S, Itil O, Akoglu S. Legionella pneumonia with acute respiratory distress syndrome, myocarditis and septic shock successfully treated with Drotrecogin Alpha (activated). Eur J Anaesthesiol 2006;23:808-810.
11. Jarasch N, Martin U, Zell R, Wutzler P, Henke A. Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19\+ B lymphocytes. Apoptosis 2007;12:1633-1643.
12. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosup-pressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857-863.
13. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immuno-suppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-2002.
14. Frustaci A, Perrone GA, Gentiloni N, Russo MA. Reversible dilated cardio-myopathy due to growth hormone deficiency. Am J Clin Pathol 1992;97: 503-511.